Kevin Gustafson - Invesco Dynamic Chief Compliance Officer
| PJP Etf | USD 87.06 0.33 0.38% |
Kevin R. Gustafson is a General Counsel and Chief Compliance Officer, PowerShares Capital Management LLC Attorney, Nyberg Gustafson Attorney, Burke, Warren, McKay Serritella, P.C. .
| Age | 42 |
| Tenure | 20 years |
| Phone | 800 983-0903 |
| Web | www.invescopowershares.com |
| Issuer | Invesco |
| Inception Date | 2005-06-23 |
| Benchmark | Dynamic Pharmaceutical Intellidex Index |
| Entity Type | Regulated Investment Company |
| Average Trading Valume | 7,072.4 |
| Asset Type | Equity |
| Category | Sector |
| Focus | Health Care |
| Market Concentration | Developed Markets |
| Region | North America |
Invesco Dynamic Management Efficiency
The company has Return on Asset of 1.02 % which means that on every $100 spent on assets, it made $1.02 of profit. This is way below average. Invesco Dynamic's management efficiency ratios could be used to measure how well Invesco Dynamic manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
| Showing other executives | One Year Return | ||
| Marc Kole | Invesco Dynamic Food | 52 | |
| Keith Ovitt | Invesco Dynamic Food | 49 | |
| Chad Hallett | SPDR SP Pharmaceuticals | 46 | |
| Mary Zeven | SPDR SP Pharmaceuticals | 51 | |
| Peter Ambrosini | SPDR SP Pharmaceuticals | 68 | |
| Charles Hurty | iShares Pharmaceuticals ETF | 72 | |
| Ronn Bagge | Invesco Dynamic Biotechnology | 54 | |
| Dave Kelly | SPDR SP Pharmaceuticals | N/A | |
| Philip Nussbaum | Invesco Dynamic Biotechnology | 51 | |
| Eilleen Clavere | iShares Pharmaceuticals ETF | 60 | |
| Robert Silver | iShares Pharmaceuticals ETF | 57 | |
| Ronn Bagge | Invesco Dynamic Food | 54 | |
| Frank Nesvet | SPDR SP Pharmaceuticals | 68 | |
| Marc Kole | Invesco Dynamic Biotechnology | 52 | |
| Philip Nussbaum | Invesco Dynamic Food | 51 | |
| Gary French | SPDR SP Pharmaceuticals | 67 | |
| John Clark | SPDR SP Pharmaceuticals | 45 | |
| Robert Kapito | iShares Pharmaceuticals ETF | 62 | |
| Madhav Rajan | iShares Pharmaceuticals ETF | 52 | |
| Helen Peters | SPDR SP Pharmaceuticals | 71 | |
| Scott Zoltowski | SPDR SP Pharmaceuticals | 43 | |
Management Performance
| Return On Equity | 1.0E-4 | |||
| Return On Asset | 1.02 |
Invesco Dynamic Phar Money Managers
| Keith Ovitt, Secretary | ||
| H Bond, Chairman of the Board of Trustee, Chief Executive Officer | ||
| Philip Nussbaum, Trustee | ||
| Ronn Bagge, Trustee | ||
| Kevin Gustafson, Chief Compliance Officer | ||
| D McMillan, Trustee | ||
| Donald Wilson, Trustee | ||
| Bruce Duncan, Chief Financial Officer, Treasurer | ||
| Marc Kole, Trustee |
Invesco Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is Invesco Dynamic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 1.0E-4 | |||
| Return On Asset | 1.02 | |||
| Profit Margin | 0.01 % | |||
| Price To Earning | 4.56 X | |||
| Price To Book | 2.03 X | |||
| Price To Sales | 2.98 X | |||
| Revenue | 7.07 M | |||
| Gross Profit | 5.44 M | |||
| Net Income | 5 M | |||
| Cash And Equivalents | 288 |
Pair Trading with Invesco Dynamic
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Invesco Dynamic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco Dynamic will appreciate offsetting losses from the drop in the long position's value.Moving together with Invesco Etf
The ability to find closely correlated positions to Invesco Dynamic could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Invesco Dynamic when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Invesco Dynamic - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Invesco Dynamic Pharmaceuticals to buy it.
The correlation of Invesco Dynamic is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Invesco Dynamic moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Invesco Dynamic Phar moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Invesco Dynamic can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Invesco Dynamic Pharmaceuticals. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
The market value of Invesco Dynamic Phar is measured differently than its book value, which is the value of Invesco that is recorded on the company's balance sheet. Investors also form their own opinion of Invesco Dynamic's value that differs from its market value or its book value, called intrinsic value, which is Invesco Dynamic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Invesco Dynamic's market value can be influenced by many factors that don't directly affect Invesco Dynamic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Invesco Dynamic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Invesco Dynamic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Invesco Dynamic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.